Prostate Cancer Lab #16: The “Personalization Conundrum”
Meeting Summary How can physicians be convinced to overcome concerns of safety, reimbursement, and liability to prescribe novel regimens (personalized drug combinations, dosing, and sequences),
Recent Comments